Homa Ahmadzia, MD, MPH
Dr. Homa K. Ahmadzia is a specialty care physician board certified in obstetrics and gynecology and maternal-fetal medicine. She joined Inova in 2023 as the Deputy Director of the Perinatal Research Unit and has been practicing since 2008.
Dr. Ahmadzia is a physician scientist and has presented her research at numerous conferences including meetings of the Society for Maternal-Fetal Medicine, the International Society of Thrombosis and Hemostasis, and the Foundation for Women and Girls with Blood Disorders. She has had federal funding for the past seven years that included a Clinical and Translational Science Institute KL2 Mentored Career Development Award and a K23 Career Mentored Development Award from the National Heart, Lung and Blood Institute as well as an R01 award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Her research has also received grant funding from the U.S. Food and Drug Administration and the Gates Foundation. Dr. Ahmadzia also served as the medical monitor for the Maternal-Fetal Medicine Unit Network.
Her research interests include prevention of postpartum hemorrhage using tranexamic acid, prediction of postpartum hemorrhage, public health epidemiology and global maternal health. She is the founder of UNITE GLOBE, an advocacy outreach group dedicated toward united efforts to reduce global obstetric hemorrhage.
Dr. Ahmadzia's clinical areas of interest include ultrasonography, management of high-risk pregnancies, and bleeding disorders and thrombophilias. She enjoys taking care of women during pregnancy and hopes to improve perinatal outcomes for women in the U.S. and abroad through her clinical and research interests.
Financial relationships
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:Coagulant TherapeuticsDate added:02/16/2024Date updated:12/04/2024Relationship end date:12/29/2023
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:HaemosonicsDate added:02/16/2024Date updated:12/04/2024Relationship end date:12/29/2023
-
Attribution:SelfType of financial relationship:Consulting FeeIneligible company:HemosquidDate added:02/16/2024Date updated:12/04/2024Relationship end date:12/29/2023
-
Attribution:SelfType of financial relationship:OtherIneligible company:COR2EDTopic:Speaker on postpartum hemorrhageDate added:02/16/2024Date updated:12/04/2024